Plasma Autoantibody Biomarkers For Diagnosis Of Basal-like Breast Cancer Read more about Plasma Autoantibody Biomarkers For Diagnosis Of Basal-like Breast Cancer France15868296.3Filed on 2015-12-09
Plasma Autoantibody Biomarkers For Diagnosis Of Basal-like Breast Cancer Read more about Plasma Autoantibody Biomarkers For Diagnosis Of Basal-like Breast Cancer Germany15868296.3Filed on 2015-12-09
Plasma Autoantibody Biomarkers For Diagnosis Of Basal-like Breast Cancer Read more about Plasma Autoantibody Biomarkers For Diagnosis Of Basal-like Breast Cancer Switzerland15868296.3Filed on 2015-12-09
Plasma Autoantibody Biomarkers For Diagnosis Of Basal-like Breast Cancer Read more about Plasma Autoantibody Biomarkers For Diagnosis Of Basal-like Breast Cancer Belgium15868296.3Filed on 2015-12-09
Complexes Of IL-15 And IL-15R AIpha And Uses Thereof Read more about Complexes Of IL-15 And IL-15R AIpha And Uses Thereof US Application 17/390,495Filed on 2021-07-30
METHODS FOR SELECTING THERAPY FOR A CANCER PATIENT Read more about METHODS FOR SELECTING THERAPY FOR A CANCER PATIENT US Application 17/703,005Filed on 2022-03-24
METHODS OF IDENTIFYING CELL-TYPE-SPECIFIC GENE EXPRESSION LEVELS BY DE-CONVOLVING BULK GENE EXPRESSION Read more about METHODS OF IDENTIFYING CELL-TYPE-SPECIFIC GENE EXPRESSION LEVELS BY DE-CONVOLVING BULK GENE EXPRESSION US Application 17/780,356Filed on 2022-05-26
INHIBITORS OF HISTONE DEMETHYLASES (PFI-63 AND PFI-90) FOR THE TREATMENT OF CANCER AND FOR THE INHIBITION OF HISTONE DEMETHYLASE IN CELLS Read more about INHIBITORS OF HISTONE DEMETHYLASES (PFI-63 AND PFI-90) FOR THE TREATMENT OF CANCER AND FOR THE INHIBITION OF HISTONE DEMETHYLASE IN CELLS US Application 17/777,552Filed on 2022-05-17
INHIBITORS OF HISTONE DEMETHYLASES Read more about INHIBITORS OF HISTONE DEMETHYLASES European Patent20824760.1Filed on 2022-06-17
INHIBITORS OF HISTONE DEMETHYLASES (PFI-63 AND PFI-90) FOR THE TREATMENT OF CANCER AND FOR THE INHIBITION OF HISTONE DEMETHYLASE IN CELLS Read more about INHIBITORS OF HISTONE DEMETHYLASES (PFI-63 AND PFI-90) FOR THE TREATMENT OF CANCER AND FOR THE INHIBITION OF HISTONE DEMETHYLASE IN CELLS Canada3158557Filed on 2022-05-16